School of Medicine
Showing 1-20 of 40 Results
-
Gita Chu Abhiraman
MD Student, expected graduation Spring 2025
Ph.D. Student in Immunology, admitted Autumn 2020
MSTP StudentBioGita Abhiraman is an MD/PhD Candidate at Stanford. She completed her PhD research in Immunology advised by Dr. Christopher Garcia, where she studied cytokine signaling, immune receptor structure, and protein engineering. Gita completed her bachelor's degree in Physics, with a focus in Biophysics, at Harvard University. She previously studied tumor-immune dynamics and helped to engineer the bacterial enzyme sortase for live cell-tracking applications, under the mentorship of Dr. Stephanie Dougan at the Dana-Farber Cancer Institute.
-
Cort Breuer
Ph.D. Student in Immunology, admitted Autumn 2022
BioCort Breuer is currently an Immunology PhD student in the lab of Nathan Reticker-Flynn. Cort received his BS in Biological Engineering from Cornell University in 2022, where he studied lymphatic-cancer interactions and T cell mechanosensing in the lab of Esak Lee. Previously, he worked with James Moon at Massachusetts General Hospital to develop in vivo gene therapies for the immune system and with Michelle Krogsgaard at NYU Perlmutter Cancer Center to investigate structural biology of TCR signaling. Cort’s current work focuses on mechanisms of tumor-immune tolerance and decoding the antigen specificity of T cell receptors. Drawing on his engineering background, he designs new molecular tools to record how immune cells communicate and constructs therapeutics to target impaired immune responses.
-
Anna Howley
Ph.D. Student in Immunology, admitted Autumn 2024
BioAnia Howley is an Immunology PhD student. She received her BS in Biology from College of the Holy Cross in 2022, where she investigated the function of APOBEC3G variants in the context of HIV infection. After completing her degree, she joined the Wyss Institute for Biologically Inspired Engineering at Harvard University. Using an organ-on-chip model, she studied the effects of radiation-induced injury on human bone marrow and developed an in-vitro model of Shwachman Diamond Syndrome using shRNA-based knockdown in primary CD34+ progenitor cells.
